Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Explore ways to earn credit card points without spending to unlock free rewards. Start earning today!
25,171 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
When executives cash out after a stock's triple-digit run, it can raise questions for investors. This guide explains ...
Ethereum leads as the most undervalued major crypto per recent MVRV data, while XRP, ADA, and LINK also show notable ...
As June trading hits mid-month, investors eye three mega-cap cloud leaders for renewed growth and long-term backlog s...
February market action favors growth names as earnings beat and cash flow strengthens. This report highlights three h...
Fox stock is down after announcing a Roku deal, leaving investors weighing value vs risk. This guide breaks down the ...
Greg Abel delivers his first annual letter as Berkshire’s CEO, outlining continuity after a $4.5 billion write-down o...
Bitcoin’s on-chain metrics point to a bitcoin network activity dramatic rebound, as daily transactions climb while th...
Goldman Sachs upgrades Liberty Energy and Patterson-UTI after surprising Q4 results, highlighting a growing gap betwe...
Meta’s AI model outlines multiple XRP price paths for 2026, showing a base target and upside scenarios as ETF demand ...
A major fund disclosed a sizable NEU share sale. This article unpacks what the move signals, how to interpret it, and...
Analysts are signaling a renewed appetite for Meta Platforms as ad revenue reaccelerates and AI products expand. The ...